The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 117-125

  Minegishi, Takashi ^a,b   Nakamura, Kazuto ^a,b   Yamashita, Soichi ^a   Omori, Yuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

FSH receptor; Human ovary; LH receptor; Splice variant

Indexed keywords

CHORIONIC GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; MESSENGER RNA;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; EXON; FRACTIONATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RECEPTOR DOWN REGULATION; RNA SPLICING;

ALTERNATIVE SPLICING; BIOTINYLATION; CYCLIC AMP; EXONS; FEMALE; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; IODINE RADIOISOTOPES; LYSOSOMES; MENSTRUAL CYCLE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, FSH; RECEPTORS, LH; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 33751218036     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.11.051     Document Type: Article

References (34)

1. Bai M. Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell. Signal. 16 (2004) 175-186
2. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., and Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272 (1997) 30603-30606
3. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7 (1987) 2745-2752
4. Colley N.J., Cassill J.A., Baker E.K., and Zuker C.S. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc. Natl. Acad. Sci. USA 92 (1995) 3070-3074
5. Davis D.P., Rozell T.G., Liu X., and Segaloff D.L. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol. Endocrinol. 11 (1997) 550-562
6. Dufau M.L. The luteinizing hormone receptor. Annu. Rev. Physiol. 60 (1998) 461-496
7. Elmhurst J.L., Xie Z., O'Dowd B.F., and George S.R. The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. Mol. Brain Res. 1 (2000) 63-74
8. Fabritz J., Ryan S., and Ascoli M. Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity. Biochemistry 37 (1998) 664-672
9. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 (2005) 269-277
10. Gromoll J., Eiholzer U., Nieschlag E., and Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone receptor: differential action of the luteinizing hormone (LH) and human chorionic gonadotropin (hCG). J. Clin. Endocrinol. Metab. 85 (2000) 2281-2286
11. Grosse R., Schoneberg T., Schultz G., and Gudermann T. inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol. Endocrinol. 11 (1997) 1305-1318
12. Hall C.W., Liebaers I., Di Natale P., and Neufeld E.F. Enzymic, diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol. 50 (1978) 439-456
13. Hipkin R.W., Sanchez-Yague J., and Ascoli M. Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA. Mol. Endocrinol. 6 (1992) 2210-2218
14. Hipkin R.W., Liu X., and Ascoli M. Truncation of the C-terminal tail of the follitropin (FSH) receptor does not impair the agonist-or phorbol ester-induced receptor phosphorylation and coupling. J. Biol. Chem. 270 (1995) 26683-26689
15. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
16. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54 (1985) 631-664
17. Laue L.L., Wu S.M., Kudo M., Bourdony C.J., Cutler G.B.J., Hsueh A.J., and Chan W.Y. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol. Endocrinol. 10 (1996) 987-997
18. Lavoie C., Mercier J.F., Salahpour A., Umapathy D., Breit A., Villeneuve L.R., Zhu W.Z., Xiao R.P., Lakatta E.G., Bouvier M., and Hebert T.E. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J. Biol. Chem. 277 (2002) 35402-35410
19. Min L., and Ascoli M. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol. Endocrinol. 14 (2000) 1797-1810
20. Minegishi T., Nakamura K., Takakura Y., Miyamoto K., Hasegawa Y., and Ibuki Y. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem. Biophys. Res. Commun. 172 (1990) 1049-1054
21. Minegishi T., Nakamura K., Takakura Y., Ibuki Y., Igarashi M., and Minegish T. Cloning and sequencing of human FSH receptor cDNA. Biochem. Biophys. Res. Commun. 175 (1991) 1125-1130
22. Minegishi T., Tano M., Abe Y., Nakamura K., Ibuki Y., and Miyamoto K. Expression of luteinizing hormone/human chorionic gonadotropin (LH/HCG) receptor mRNA in the human ovary. Mol. Hum. Reprod. 3 (1997) 101-107
23. Minegishi T., Tano M., Igarashi M., Rokukawa S., Abe Y., Ibuki Y., and Miyamoto K. Expression of follicle-stimulating hormone receptor in human ovary. Eur. J. Clin. Invest. 27 (1997) 469-474
24. Nakamura K., and Ascoli M. Adileucine-based motif in the C-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complex. Mol. Pharmacol. 56 (1999) 728-736
25. Quintana J., Hipkin R.W., and Ascoli M. A polyclonal antibody to a synthetic peptide derived from the rat FSH receptor reveals the recombinant receptor as a 74 kDa protein. Endocrinology 133 (1993) 2096-2104
26. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C., and Patel Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275 (2000) 7862-7869
27. Rozell T.G., Davis D.P., Chai Y., and Segaloff D.L. Association of gonadotropin receptor precursors with the protein folding chaperone calnexin. Endocrinology 139 (1998) 1588-1593
28. Rozzell T.G., Wang H., Liu X., and Segaloff D.L. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor. Mol. Endocrinol. 9 (1995) 1727-1736
29. Segaloff D.L., and Ascoli M. The lutropin/choriogonadotropin receptor... 4 years later. Endocr. Rev. 14 (1993) 324-347
30. Themmen A.P.N., and Huhtaniemi I. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev. 21 (2000) 551-583
31. VuHai-LuuThi M.T., Misrahi M., Houllier A., Jolivet A., and Milgrom E. Variant forms of the pig lutropin/choriogonadotropin receptor. Biochemistry 31 (1992) 8377-8383
32. Whaley B.S., Yuan N., Birnbaumer L., Clark R.B., and Barber R. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol. Pharmacol. 45 (1994) 481-489
33. Yamashita S., Nakamura K., Omori Y., Tsunekawa K., Murakami M., and Minegishi T. Association of human follitropin (FSH) receptor with splicing variant of human lutropin/choriogonadotropin receptor negatively controls the expression of human FSH receptor. Mol. Endocrinol. 19 (2005) 2099-2111
34. Zhu X., and Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37 (1998) 15773-15784